secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sintx Technologies, Inc. (SINT)
CIK:        0001269026
Form:       8-K
Filed at:   2024-11-19T23:59:59+00:00
Accession:  0001493152-24-046863
Event type: leadership
Sentiment:  positive
Materiality: 0.35
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SINTX appoints Gregg Honigblum as Chief Strategy Officer; 6-month term, $137,500 base salary
--------------------------------------------------------------------------------

- Gregg Honigblum appointed CSO effective Nov 15, 2024; previously Managing Director at FNEX Capital.
- Employment agreement: 6-month term, $137,500 base salary, eligible for bonuses and equity awards.
- Severance if terminated without cause: base salary for longer of 3 months or remainder of term.
- Honigblum has over 35 years experience in healthcare and investment banking; raised over $500M.
- Instrumental in early-stage capital for Myriad Genetics and early investor in Acacia Biosciences.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1269026/000149315224046863/0001493152-24-046863-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1269026/000149315224046863/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-046863

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer